SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,075 | -55.8% | 15,164 | +1.1% | 0.00% | -50.0% |
| Q2 2023 | $705,488 | +1.0% | 15,004 | -9.9% | 0.00% | 0.0% |
| Q1 2023 | $698,382 | +10.0% | 16,644 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $634,802 | -23.4% | 16,644 | -21.4% | 0.00% | 0.0% |
| Q3 2022 | $829,000 | +21.2% | 21,164 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $684,000 | -75.4% | 21,164 | -74.8% | 0.00% | -60.0% |
| Q1 2022 | $2,785,000 | -22.9% | 84,140 | -1.0% | 0.01% | -16.7% |
| Q4 2021 | $3,614,000 | -4.5% | 84,950 | -0.5% | 0.01% | -14.3% |
| Q3 2021 | $3,785,000 | -25.5% | 85,412 | -4.5% | 0.01% | -30.0% |
| Q2 2021 | $5,078,000 | -4.5% | 89,392 | +25.9% | 0.01% | -9.1% |
| Q1 2021 | $5,316,000 | -22.0% | 71,028 | -9.8% | 0.01% | -21.4% |
| Q4 2020 | $6,815,000 | +37.0% | 78,778 | -3.2% | 0.01% | +27.3% |
| Q3 2020 | $4,974,000 | +65.1% | 81,373 | +12.3% | 0.01% | +57.1% |
| Q2 2020 | $3,013,000 | +53.6% | 72,463 | +6.1% | 0.01% | +16.7% |
| Q1 2020 | $1,961,000 | -59.7% | 68,266 | +1.2% | 0.01% | -50.0% |
| Q4 2019 | $4,871,000 | -48.9% | 67,477 | -0.8% | 0.01% | -52.0% |
| Q3 2019 | $9,539,000 | -24.6% | 67,997 | -1.6% | 0.02% | -24.2% |
| Q2 2019 | $12,656,000 | +27.6% | 69,125 | +10.8% | 0.03% | +26.9% |
| Q1 2019 | $9,920,000 | +67.1% | 62,371 | +0.6% | 0.03% | +44.4% |
| Q4 2018 | $5,937,000 | -23.9% | 61,981 | +12.2% | 0.02% | -10.0% |
| Q3 2018 | $7,803,000 | -8.5% | 55,242 | +1.4% | 0.02% | -13.0% |
| Q2 2018 | $8,525,000 | +133.7% | 54,461 | +140.4% | 0.02% | +130.0% |
| Q1 2018 | $3,648,000 | +5.5% | 22,651 | +7.9% | 0.01% | +11.1% |
| Q4 2017 | $3,458,000 | +229.3% | 20,992 | +24.6% | 0.01% | +200.0% |
| Q3 2017 | $1,050,000 | +3.4% | 16,852 | +32.3% | 0.00% | 0.0% |
| Q2 2017 | $1,015,000 | +18.4% | 12,742 | +5.7% | 0.00% | +50.0% |
| Q1 2017 | $857,000 | +39.1% | 12,056 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $616,000 | +18.9% | 12,056 | +7.1% | 0.00% | 0.0% |
| Q3 2016 | $518,000 | +66.6% | 11,256 | +9.1% | 0.00% | +100.0% |
| Q2 2016 | $311,000 | +42.0% | 10,316 | +51.2% | 0.00% | 0.0% |
| Q1 2016 | $219,000 | -43.8% | 6,822 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $390,000 | +45.5% | 6,692 | +5.9% | 0.00% | 0.0% |
| Q3 2015 | $268,000 | -8.8% | 6,322 | +57.2% | 0.00% | 0.0% |
| Q2 2015 | $294,000 | – | 4,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |